These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6360888)

  • 21. Hypoxia mediates increased neutrophil and macrophage adhesiveness to alveolar epithelial cells.
    Beck-Schimmer B; Schimmer RC; Madjdpour C; Bonvini JM; Pasch T; Ward PA
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):780-7. PubMed ID: 11726405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of alveolar macrophage production of chemoattractants by leukotriene B4 and prostaglandin E2.
    Christman JW; Christman BW; Shepherd VL; Rinaldo JE
    Am J Respir Cell Mol Biol; 1991 Sep; 5(3):297-304. PubMed ID: 1654953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.
    Gadek JE; Hunninghake GW; Zimmerman RL; Crystal RG
    Am Rev Respir Dis; 1980 Apr; 121(4):723-33. PubMed ID: 6992662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation.
    Harmsen AG
    Infect Immun; 1988 Aug; 56(8):1858-63. PubMed ID: 3397176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
    Martin TR; Raugi G; Merritt TL; Henderson WR
    J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization.
    Merrill WW; Naegel GP; Matthay RA; Reynolds HY
    J Clin Invest; 1980 Feb; 65(2):268-76. PubMed ID: 7356678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum factor requirement for reactive oxygen intermediate release by rabbit alveolar macrophages.
    Gerberick GF; Willoughby JB; Willoughby WF
    J Exp Med; 1985 Feb; 161(2):392-408. PubMed ID: 2982990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic effect of Pasteurella haemolytica on bovine polymorphonuclear leukocytes and impaired production of chemotactic factors by Pasteurella haemolytica-infected alveolar macrophages.
    Markham RJ; Ramnaraine ML; Muscoplat CC
    Am J Vet Res; 1982 Feb; 43(2):285-8. PubMed ID: 7091828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of culture filtrates of Blastomyces dermatitidis on neutrophil locomotion.
    Mitchell TG; Turner SR
    Sabouraudia; 1984; 22(2):145-53. PubMed ID: 6374935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and partial characterization of a human alveolar macrophage-derived neutrophil-activating factor.
    Pennington JE; Rossing TH; Boerth LW; Lee TH
    J Clin Invest; 1985 Apr; 75(4):1230-7. PubMed ID: 2985653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hyperoxia on reduced glutathione in alveolar macrophages and polymorphonuclear leukocytes.
    Rister M; Wustrow C
    Res Exp Med (Berl); 1985; 185(6):445-50. PubMed ID: 4089311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human alveolar macrophages release a factor that inhibits phagocyte function.
    Sibille Y; Merrill WW; Naegel GP; Care SB; Cooper JA; Reynolds HY
    Am J Respir Cell Mol Biol; 1989 Nov; 1(5):407-16. PubMed ID: 2561589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil chemotactic factor release and neutrophil alveolitis in asbestos-exposed individuals.
    Hayes AA; Rose AH; Musk AW; Robinson BW
    Chest; 1988 Sep; 94(3):521-5. PubMed ID: 3044701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordant pulmonary proinflammatory cytokine expression during acute hyperoxia in the newborn rabbit.
    D'Angio CT; LoMonaco MB; Chaudhry SA; Paxhia A; Ryan RM
    Exp Lung Res; 1999; 25(5):443-65. PubMed ID: 10483526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats.
    Deng H; Mason SN; Auten RL
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2316-23. PubMed ID: 11112157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of in vitro exposure to nitrogen dioxide on human alveolar macrophage release of neutrophil chemotactic factor and interleukin-1.
    Pinkston P; Smeglin A; Roberts NJ; Gibb FR; Morrow PE; Utell MJ
    Environ Res; 1988 Oct; 47(1):48-58. PubMed ID: 3049064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of neutrophil recruitment to the lung by grain dust exposure.
    Von Essen SG; Robbins RA; Thompson AB; Ertl RF; Linder J; Rennard S
    Am Rev Respir Dis; 1988 Oct; 138(4):921-7. PubMed ID: 3059885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta.
    Strieter RM; Chensue SW; Basha MA; Standiford TJ; Lynch JP; Baggiolini M; Kunkel SL
    Am J Respir Cell Mol Biol; 1990 Apr; 2(4):321-6. PubMed ID: 2182081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between pulmonary inflammation, plasma transudation, and oxygen metabolite secretion by alveolar macrophages.
    Gerberick GF; Jaffe HA; Willoughby JB; Willoughby WF
    J Immunol; 1986 Jul; 137(1):114-21. PubMed ID: 3486910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.